// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The Effects of (Patho)Physiological Fibrinogen γ’ Levels on Static and Dynamic Clot Formation

F. Macrae - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

The Effects of EDTA as an Anticoagulant and Delayed Processing on the Measurement of Plasma VWF Antigen

M.C. Sims - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Influence of Anemia on Clinical Outcomes in Venous Thromboembolism: Results from GARFIELD-VTE

S. Goto - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Influence of Prothrombin Complex Concentrates on Clot Stability

C.D. Garcia - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prothrombin complex

The Misfolded Protein Glycated Albumin Activates the Contact System Leading to Plasma Kallikrein Activity But Not Intrinsic Coagulation

L. Hardy - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Protamine Sulfate

The Obstetric Experience of Carriers of Haemophilia

O. Turan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Hemophilia

N/A

The Presence of Paraproteinaemia in Patients with Antiphospholipid Syndrome – A Single Centre Case Series

A. Doyle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Antiphospholipid syndrome

N/A

The Psychosocial Impact of Venous Thromboembolism: An Exploratory Systematic Review and Narrative Synthesis

G. Saul - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Relationship between Societal Costs Associated with Haemophilia and Disease Severity: A Regression Analysis Using CHESS II Data

T. Burke - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

The Role of Antithrombin in Complement Activation: Pilot Data from Patients with Inherited Antithrombin Deficiency

K. Mayger - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Role of Coagulation-generated Components on GPVI-mediated Platelet Activation

I. De Simone - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Sensitivity of Two New APTT Reagents to Factors VIII, IX and XI

A. Bowyer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

FVIII

The Throm-PED Registry: The Cornerstone of the International Pediatric Thrombosis Network

C.H. van Ommen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Tissue Factor Expression of Monocyte Subsets and the Activation of Coagulation during Human Endotoxaemia

K. Musgrave - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Evithrom

The Tissue Factor Surface Expression of Monocyte Subsets during Sepsis

K.M. Musgrave - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

The Use of ADJUST (age-adjusted) D-Dimer Cut-off in the Assessment of Individuals Over 50 Years Old with Suspected Deep Vein Thromboses Can Decrease the Need for Compression Ultrasonography: Initial Results of a Prospective Primary Care Study

A. Hughes - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of an Automated Thrombin Generation Assay for the Measurement of Emicizumab and Recombinant Factor VIII in Spiked Plasma

A. Bowyer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Recombinant Factor VIII

The Use of Fondaparinux for Recurrent Thrombotic Events

Z. Sayar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Thrombotic disorder

Fondaparinux sodium

The Use of Platelet Transfusions during Extracorporeal Membrane Oxygenation in a Large Tertiary Centre

A. Doyle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Thrombin Generation Potential of Modified FIX: Dalcinonacog Alfa

S. Williams - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Evithrom

Copyright © 2026. QuantiNova All rights reserved